Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


DelAversano Robert J Create: Alert

All | News | Filings
Date FiledTypeDescription
02/09/2023 4 DelAversano Robert J (VP, Finance) has filed a Form 4 on ONCOSEC MEDICAL Inc
Txns: Sold 40 shares @ $1.37, valued at $54.8
11/04/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/05/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/11/2022 4 DelAversano Robert J (VP, Finance) has filed a Form 4 on ONCOSEC MEDICAL Inc
Txns: Sold 409 shares @ $0.88, valued at $359.9
11/03/2021 4 DelAversano Robert J (VP, Finance) has filed a Form 4 on ONCOSEC MEDICAL Inc
Txns: Sold 343 shares @ $1.75, valued at $600.3
08/03/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/29/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/04/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/03/2021 4 DelAversano Robert J (Principal Accounting Officer) has filed a Form 4 on ONCOSEC MEDICAL Inc
Txns: Granted 8,750 shares @ $0
08/26/2020 4 DelAversano Robert J (Principal Accounting Officer) has filed a Form 4 on ONCOSEC MEDICAL Inc
Txns: Granted 27,000 options to buy @ $3.82, valued at $103.1k
06/03/2020 4 DelAversano Robert J (Principal Accounting Officer) has filed a Form 4 on ONCOSEC MEDICAL Inc
Txns: Granted 25,362 shares @ $0
Paid exercise price by delivering 8,679 shares @ $2.23, valued at $19.4k
Granted 54,054 options to buy @ $1.56, valued at $84.3k
02/12/2020 3 DelAversano Robert J (Principal Accounting Officer) has filed a Form 3 on ONCOSEC MEDICAL Inc
04/12/2018 4 DelAversano Robert J (See Remarks) has filed a Form 4 on U.S. GOLD CORP.
Txns: Granted 50,000 options @ $1.45, valued at $72.5k
01/17/2018 3 DelAversano Robert J (Principal Financial Officer) has filed a Form 3 on U.S. GOLD CORP.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy